BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25535168)

  • 1. [Medical therapies for locally advanced/metastatic kidney cancer].
    Afrit M; Yahyaoui Y; Bouzouita A; Hantous S; Labidi S; Chebil M; Ben Miled K; Escudier B; Boussen H
    Presse Med; 2015 Feb; 44(2):135-43. PubMed ID: 25535168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.
    Sfoungaristos S; Giannitsas K; Perimenis P
    Expert Opin Pharmacother; 2011 Mar; 12(4):533-47. PubMed ID: 21306289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
    Parton M; Gore M; Eisen T
    J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic renal cell carcinoma: systemic treatment.
    Abi-Aad AS; deKernion JB
    Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant therapy for locally advanced renal cell carcinoma: A meta-analysis and systematic review.
    Bai Y; Li S; Jia Z; Ding Y; Gu C; Yang J
    Urol Oncol; 2018 Feb; 36(2):79.e1-79.e10. PubMed ID: 29110942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment selection in metastatic renal cell carcinoma: more confusion or a path forward?
    Hirsch BR; George DJ; Harrison MR
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):163-71. PubMed ID: 24927264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
    Gupta SK; Vogelzang N
    Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
    [No Abstract]   [Full Text] [Related]  

  • 8. New treatments for metastatic kidney cancer.
    Mancuso A; Sternberg CN
    Can J Urol; 2005 Feb; 12 Suppl 1():66-70; discussion 105. PubMed ID: 15780170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment options in patients with metastatic renal cell carcinoma.
    Haferkamp A; Hohenfellner M
    Nephrol Dial Transplant; 2007 Apr; 22(4):996-9. PubMed ID: 17210591
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
    Miller K; Bergmann L; Gschwend J; Keilholz U; Kuczyk M; Wirth M
    Aktuelle Urol; 2013 Jan; 44(1):45-9. PubMed ID: 23015607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of renal cell carcinoma: results from current phase-III-trials].
    Doehn C; Jocham D
    Aktuelle Urol; 2004 Apr; 35(2):121-9. PubMed ID: 15146376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and targeted therapies in metastatic renal cell carcinoma: is there a preferred sequence?
    Giuliani J; Drudi F
    Cancer Biother Radiopharm; 2012 Oct; 27(8):513-8. PubMed ID: 22738404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic opportunities in metastatic renal cell carcinoma].
    Buess M
    Praxis (Bern 1994); 2009 Apr; 98(9):481-6. PubMed ID: 19404907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.
    Thomas JS; Kabbinavar F
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy for metastatic renal cell carcinoma.
    McDermott DF; Rini BI
    BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
    [No Abstract]   [Full Text] [Related]  

  • 18. Considerations for the design of future clinical trials in metastatic renal cell carcinoma.
    Escudier B; Heng DY; Smyth-Medina A; Porta C
    Clin Genitourin Cancer; 2014 Feb; 12(1):1-12. PubMed ID: 24220221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
    Köpke T; Bierer S; Wülfing C; Tiemann A; Hertle L; Herrmann E
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):763-71. PubMed ID: 19496713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for advanced renal cell carcinoma.
    Meissner MA; McCormick BZ; Karam JA; Wood CG
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):663-671. PubMed ID: 29707987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.